Your browser doesn't support javascript.
loading
Association of HLA-DRB1*15:02:01, DQB1*05:01:24 and DPB1*13:01:01 in Thai patients with systemic sclerosis.
Louthrenoo, Worawit; Kasitanon, Nuntana; Wongthanee, Antika; Okudaira, Yuko; Takeuchi, Masumi; Nakajima, Fumiaki; Habata, Miwa; Masuya, Anri; Noguchi, Hiroshi; Inoko, Hidetoshi; Takeuchi, Fujio.
Afiliação
  • Louthrenoo W; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Kasitanon N; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Wongthanee A; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Okudaira Y; GenoDive Pharma Inc., Naka-cho Honatugi, Kanagawa, Japan.
  • Takeuchi M; Graduate School of Human Development and Environment, Kobe University, Kobe, Japan.
  • Nakajima F; GenoDive Pharma Inc., Naka-cho Honatugi, Kanagawa, Japan.
  • Habata M; GenoDive Pharma Inc., Naka-cho Honatugi, Kanagawa, Japan.
  • Masuya A; GenoDive Pharma Inc., Naka-cho Honatugi, Kanagawa, Japan.
  • Noguchi H; School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
  • Inoko H; GenoDive Pharma Inc., Naka-cho Honatugi, Kanagawa, Japan.
  • Takeuchi F; School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
HLA ; 100(6): 563-581, 2022 12.
Article em En | MEDLINE | ID: mdl-36054790
ABSTRACT
HLA studies in patients with systemic sclerosis (SSc) have shown variable results. This study aimed to examine the association of HLA class I and II risk alleles in Thai SSc patients, and clarify the contribution of risk HLA alleles to the pathogenesis and clinical manifestations. Blood samples from 92 SSc patients and 135 healthy controls (HCs) were collected. Eleven loci of the HLA class I (HLA-A, B, and C) and class II (HLA-DR, DP, and DQ) genes were determined by a 3-field (6-digit) analysis using the Next Generation DNA Sequencing (NGS) method. Anti-topoisomerase-I antibodies (ATA) and anti-centromere antibodies (ACA) were identified by ELISA methods. Allele frequencies (AFs) of HLA-DRB1*150201, DRB5*010201, DQB1*050124, DPB1*130101, and DQA1*010101 were increased significantly in the whole SSc and SSc patients with positive ATA, but with negative ACA (SSc/ATA+/ACA-). Of these, DPB1*130101 was the most susceptible allele. The DRB1*150201, DQB1050124, and DPB1*130101 alleles were estimated to locate on the unique haplotype, and haplotype frequency was estimated to be significantly higher than those in the HCs (p = 0.002). The linkage analysis of DRB1*15/16 revealed that most of the DRB1*150201 alleles were linked to DRB5*010201 or DRB5*010801N. The linkage of DRB1*160201 to DRB5*010101 was observed frequently. The associations of risk alleles with several SSc clinical features were observed. HLA-DRB1*150201, DRB5*010201, DQB1*050124, and DPB1*130101 on the unique haplotype were associated with the pathogenesis and clinical features of SSc in Thai patients. The linkage of DRB1*150201 to DRB5*010801N was observed commonly in northern Thai patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article